Application of Pyrrolidine in FDA‐Approved Drugs

Jiao Wang, Xiaolin Tan, Xiaoyan Wang, Yatao Wang, Hui Li, Zhong Yu, Qifang Liu

Open source

DOI
10.1002/med.70100
Published
2026-08-18
Container
Medicinal Research Reviews
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/med.70100,
  title = {Application of Pyrrolidine in FDA‐Approved Drugs},
  author = {Jiao Wang and Xiaolin Tan and Xiaoyan Wang and Yatao Wang and Hui Li and Zhong Yu and Qifang Liu},
  year = {2026},
  journal = {Medicinal Research Reviews},
  doi = {10.1002/med.70100},
  url = {https://doi.org/10.1002/med.70100}
}

RIS

TY  - JOUR
TI  - Application of Pyrrolidine in FDA‐Approved Drugs
AU  - Jiao Wang
AU  - Xiaolin Tan
AU  - Xiaoyan Wang
AU  - Yatao Wang
AU  - Hui Li
AU  - Zhong Yu
AU  - Qifang Liu
PY  - 2026
JO  - Medicinal Research Reviews
DO  - 10.1002/med.70100
UR  - https://doi.org/10.1002/med.70100
ER  - 

APA

Wang, J., Tan, X., Wang, X., Wang, Y., Li, H., Yu, Z., & Liu, Q. (2026). Application of Pyrrolidine in FDA‐Approved Drugs. Medicinal Research Reviews. https://doi.org/10.1002/med.70100

Source records